NCT03760003 2025-11-28
Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis
Abivax S.A.
Phase 2 Completed
Clinical Trials
3 trialsNCT05156125 2024-11-13
VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
Oppilan Pharma Ltd
Phase 2 Active not recruiting
NCT01520324 2019-02-08
Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy
CosmoTech
Phase 2 Completed